Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Research-grade cranberry

This article was originally published in The Tan Sheet

Executive Summary

McKesson's BioServices division has inked a five-year, $2.8 mil. contract with NCCAM to develop research-grade cranberry products for center-funded basic, clinical research on role of cranberry "in the prevention and treatment of urinary tract infections" and other applications, firm says Oct. 23. McKesson will subcontract with Ocean Spray, which will donate "research product and analytical research services." Test batches and prototypes are being developed now for a cranberry capsule, placebo capsule, standardized juice cocktail similar to firm's flagship beverage and placebo beverage that replicates cocktail flavor without cranberry. McKesson's responsibilities will include labeling, storage, distribution and delivery of products. Actual product for use in research expected in Fall 2003...

Related Content

Cranberry Research Supported With $2.6 Mil. In NIH Funding





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts